[HTML][HTML] Pharmacokinetic and pharmacodynamic interaction of Rosuvastatin calcium with guggulipid extract in rats
Background & objectives Rosuvastatin calcium (RC) is a potent and competitive synthetic
inhibitor of HMG-CoA reductase used for the treatment of dyslipidemia. Guggulipid obtained …
inhibitor of HMG-CoA reductase used for the treatment of dyslipidemia. Guggulipid obtained …
Antihyperlipidemic activity and HMG CoA reductase inhibition of ethanolic extract of zingiber cassumunar roxb in fructose-induced hyperlipidemic wistar rats
the side effects of using simvastatin as a blood cholesterol-lowering drug can lead to toxic
myopathy [7].[...] many hyperlipidemia patients prefer to use medicinal plants as an …
myopathy [7].[...] many hyperlipidemia patients prefer to use medicinal plants as an …
A comparative randomized study of Guggulu and Atorvastatin Hypercholesterolemia patients
C Nagabhushanam, PR Babu, NK Devi… - Research Journal of …, 2010 - indianjournals.com
Obesity is an important health hazard a known risk factor for several diseases like coronary
heart disease (CHD), angina pectoris hypertension, cardiac failure etc… Recent …
heart disease (CHD), angina pectoris hypertension, cardiac failure etc… Recent …
A comparative study of lipid-lowering effects of guggul and atorvastatin monotherapy in comparison to their combination in high cholesterol diet-induced …
S Das, A Datta, C Bagchi, S Chakraborty… - Journal of dietary …, 2016 - Taylor & Francis
Background: Hypolipidemic activity of gugulipid has been widely described in traditional
literature. Objective: This study was done to evaluate hypolipidemic activity of guggul and …
literature. Objective: This study was done to evaluate hypolipidemic activity of guggul and …
[HTML][HTML] Inhibitory effects of tangeretin and trans-ethyl caffeate on the HMG-CoA reductase activity: Potential agents for reducing cholesterol levels
I Pangestika, E Oksal, TST Muhammad, H Amir… - Saudi journal of …, 2020 - Elsevier
One of the pathways to reduce cholesterol production in the liver is through the inhibition of
HMG-Coa reductase (HMGCR) by current drugs, statins. However, these have side effects if …
HMG-Coa reductase (HMGCR) by current drugs, statins. However, these have side effects if …
Rhus coriaria L.(sumac) in patients with hyperlipidemia; a double blind randomized clinical trial
Z Hajmohammadi, M Shams… - Iranian journal of …, 2016 - ncbi.nlm.nih.gov
Background: Lipid lowering effect of sumac is investigated in multiple animal studies with
promising results. However, its clinical efficacy is not investigated adequately. This study is …
promising results. However, its clinical efficacy is not investigated adequately. This study is …
[PDF][PDF] Potential additive effects of Garcinia cambogia on atorvastatin treated hyperlipidemic patients: randomized crossover clinical study
HM Alkuraishy, AI Algareeb, AK Albuhadilly… - International Journal of …, 2014 - academia.edu
Background: Dyslipidemia is a major risk factor linking in the direction of the progression of
ischemic heart diseases, which is measured to be the chief principal reason of international …
ischemic heart diseases, which is measured to be the chief principal reason of international …
Effects of Ethanolic Extract of Schisandra sphenanthera on the Pharmacokinetics of Rosuvastatin in Rats
Q Sun, L Li, Q Zhou - Drug Design, Development and Therapy, 2023 - Taylor & Francis
Purpose Wuzhi capsule (WZ) is a proprietary Chinese medicine prepared from the ethanolic
extract of Schisandra sphenanthera that is commonly used to treat liver injury. Statins are …
extract of Schisandra sphenanthera that is commonly used to treat liver injury. Statins are …
[HTML][HTML] Comparative study of hypolipidemic effects of Momordica Charantia (karela) with atorvastatin in fat fed rats
ZR Sharmin, MT Akter, R Rahman… - Journal of Human …, 2017 - oap-lifescience.org
Background: Disorders of lipid metabolism are manifested by elevation of the plasma
concentration of the various lipid and lipoprotein fractions and the result, predominantly …
concentration of the various lipid and lipoprotein fractions and the result, predominantly …
Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
GD Reddy, AG Reddy, GS Rao… - Indian journal of …, 2012 - journals.lww.com
Objective: To assess pharmacokinetic interaction of garlic with atorvastatin in dyslipidemic
rats. Materials and Methods: Sprague Dawley rats with induced dyslipidemia were divided …
rats. Materials and Methods: Sprague Dawley rats with induced dyslipidemia were divided …